Physician profile
Robert M Holley
NPI 1295834810
$2,565.80
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $795 · 2021: $709 · 2022: $501.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $567.01 | 2019-2022 | |
| Glaxosmithkline, LLC. | $512.43 | 2019-2022 | |
| Abbvie INC. | $235.57 | 2020-2022 | |
| Abbott Laboratories | $201.24 | 2020-2022 | |
| Amgen INC. | $200.71 | 2019-2022 | |
| Amarin Pharma, INC. | $188.60 | 2019-2021 | |
| Vifor Pharma, INC. | $115.25 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.07 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $80.90 | 2020-2022 | |
| Allergan, INC. | $74.33 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $61.47 | 2021-2022 | |
| Esperion Therapeutics, INC. | $54.57 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $43.61 | 2020 | |
| Lilly USA, LLC | $33.55 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.15 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $28.01 | 2021 | |
| Novo Nordisk INC | $26.95 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $14.23 | 2019 | |
| Shire North American Group INC | $12.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Holley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.